Publicaties
2025
Wetenschappelijke publicaties
van Vliet, E. D., Buhl, C., Jacobsen, R., Andersen, A., Almarsdóttir, A. B., Dermiki-Gkana, F., Oikonomou, C., Deligianni, E., Kontogiorgis, C., Kos, M., Čebron Lipovec, N., Ribeiro-Vaz, I., Silva, A. M., Ferreira, P., Poplavska, E., Abtahi, S., Hegger, I., & Leonardo Alves, T. (2025). Perspectives on the impact of regulatory measures on national COVID-19 vaccination programs: a qualitative study from six EU member states. Journal of Pharmaceutical Policy and Practice, 18(1), 2576620. [DOI]
Kanning, J. P., Abtahi, S., Klungel, O. H., & Ruigrok, Y. M. (2025). Author Response: Prescribed Drug Use and Aneurysmal Subarachnoid Hemorrhage Incidence: A Drug-Wide Association Study. Neurology, 104(12), Article e210035. [DOI]
2024
Wetenschappelijke publicaties
van Vliet, E., Lipovec, N. Č., van der Goot, M., Abtahi, S., Ribeiro-Vaz, I., Poplavska, E., Dermiki-Gkana, F., Oikonomou, C., Deligianni, E., Kontogiorgis, C., Silva, A. M., Ferreira, P. B. S., Kos, M., Almarsdóttir, A. B., Jacobsen, R., Buhl, C., de Bruijn, A., Hegger, I., & Alves, T. L. (2024). Impact of Regulatory Risk Communication on Thrombosis With Thrombocytopenia Syndrome for COVID-19 Adenovirus Vector Vaccines on European Healthcare Professionals. Pharmacoepidemiology and Drug Safety, 33(12), Article e70057. [DOI] [Portal]
Iversen, D. B., Dunvald, A.-C. D., Ernst, M. T., Abtahi, S., Souverein, P., Klungel, O., Jeppesen, G. B., Nielsen, F., Brøsen, K., Hammer, H. S., Pötz, O., Damkier, P., Järvinen, E., Pottegård, A., & Stage, T. B. (2024). Dicloxacillin is an inducer of intestinal P-glycoprotein but neither dicloxacillin nor flucloxacillin increases the risk of stroke/systemic embolism in direct oral anticoagulant users. British Journal of Clinical Pharmacology, 90(12), 3252-3262. [DOI] [Portal]
Buhl, C., Jacobsen, R., Almarsdóttir, A. B., Abtahi, S., Andersen, A., Deligianni, E., Dermiki-Gkana, F., Kontogiorgis, C., Oikonomou, C., Kursite, M., Poplavska, E., Hegger, I., Goot, M. V. D., Ferreira, P. B. S., Ribeiro-Vaz, I., Silva, A. M., Kos, M., Lipovec, N. Č., Vliet, E. V., & Alves, T. L. (2024). Public's perspective on COVID-19 adenovirus vector vaccines after thrombosis with thrombocytopenia syndrome (TTS) reports and associated regulatory actions: A cross-sectional study in six EU member states. Vaccine, 42(3), 556-563. [DOI] [Repository]
2023
Wetenschappelijke publicaties
Tsai, D. H.-T., Bell, J. S., Abtahi, S., Baak, B. N., Bazelier, M. T., Brauer, R., Chan, A. Y. L., Chan, E. W., Chen, H., Chui, C. S. L., Cook, S., Crystal, S., Gandhi, P., Hartikainen, S., Ho, F. K., Hsu, S.-T., Ilomäki, J., Kim, J. H., Klungel, O. H., ... Lai, E. C.-C. (2023). Cross-Regional Data Initiative for the Assessment and Development of Treatment for Neurological and Mental Disorders. Clinical Epidemiology, 2023(15), 1241-1252. [DOI] [Repository]
Durán, C. E., Riera-Arnau, J., Abtahi, S., Pajouheshnia, R., Hoxhaj, V., Gamba, M., Alsina, E., Martin-Perez, M., Garcia-Poza, P., Llorente-Garcia, A., Gonzalez-Bermejo, D., Ibánez, L., Sabaté, M., Vidal, X., Ballarín, E., Sanfélix-Gimeno, G., Rodríguez-Bernal, C., Peiró, S., García-Sempere, A., ... Sturkenboom, M. (2023). Impact of the 2018 revised Pregnancy Prevention Programme by the European Medicines Agency on the use of oral retinoids in females of childbearing age in Denmark, Italy, Netherlands, and Spain: an interrupted time series analysis. Frontiers in Pharmacology, 14, Article 1207976. [DOI] [Repository]
Abtahi, S., Pajouheshnia, R., Durán, C. E., Riera-Arnau, J., Gamba, M., Alsina, E., Hoxhaj, V., Andersen, M., Bartolini, C., Kristiansen, S. B., Brown, J., Hallgreen, C. E., Garcia-Poza, P., Gardarsdottir, H., Gini, R., Girardi, A., Holthuis, E., Huerta, C., Ibánez, L., ... Klungel, O. (2023). Impact of 2018 EU Risk Minimisation Measures and Revised Pregnancy Prevention Programme on Utilisation and Prescribing Trends of Medicinal Products Containing Valproate: An Interrupted Time Series Study. Drug Safety, 46(7), 689-702. [DOI] [Repository]
Abtahi, S., Driessen, J. H. M., Burden, A. M., Souverein, P. C., Van Den Bergh, J. P., & Boonen, A. (2023). Response to: 'Correspondence on 'Concomitant use of oral glucocorticoids and proton pump inhibitors and risk of osteoporotic fractures among patients with rheumatoid arthritis: A population-based cohort study' by Gong and Zhang and Lin et al. Annals of the Rheumatic Diseases, 82(6), Article e143. [DOI] [Repository]
Abtahi, S., Driessen, J. H. M., Burden, A. M., Souverein, P. C., van den Bergh, J. P., van Staa, T. P., Boonen, A., & de Vries, F. (2023). Response to: 'Correspondence on 'Concomitant use of oral glucocorticoids and proton pump inhibitors and risk of osteoporotic fractures among patients with rheumatoid arthritis: a population-based cohort study'' by Zheng. Annals of the Rheumatic Diseases, 82(4), Article e219856. [DOI] [Repository]
2022
Wetenschappelijke publicaties
van Veelen, A., Abtahi, S., Souverein, P., Driessen, J. H. M., Klungel, O. H., Dingemans, A.-M. C., van Geel, R., de Vries, F., & Croes, S. (2022). Characteristics of patients with lung cancer in clinical practice and their potential eligibility for clinical trials evaluating tyrosine kinase inhibitors or immune checkpoint inhibitors. Cancer Epidemiology, 78, 1-8. Article 102149. [DOI] [Repository]
Abtahi, S., Cordtz, R., Dreyer, L., Driessen, J. H. M., Boonen, A., & Burden, A. M. (2022). Biological disease-modifying antirheumatic drugs and osteoporotic fracture risk in patients with rheumatoid arthritis: a Danish cohort study. The American Journal of Medicine, 135(7), 879-888.e3. [DOI] [Repository]
Abtahi, S., Driessen, J. H. M., Burden, A. M., Souverein, P. C., van den Bergh, J. P., van Staa, T. P., Boonen, A., & de Vries, F. (2022). Low-dose oral glucocorticoid therapy and risk of osteoporotic fractures in patients with rheumatoid arthritis: a cohort study using the Clinical Practice Research Datalink. Rheumatology (Oxford, England), 61(4), 1448–1458. [DOI] [Repository]
2021
Wetenschappelijke publicaties
Abtahi, S. (2021). Osteoporotic Fractures: Relation to Mortality, Medication Use, and Rheumatoid Arthritis (1 ed.). [Doctoral thesis 3 (Research UU / Graduation NOT UU), Maastricht University]. Maastricht University. [DOI]
Abtahi, S., Driessen, J. H. M., Burden, A. M., Souverein, P. C., van den Bergh, J. P., van Staa, T. P., Boonen, A., & de Vries, F. (2021). Concomitant use of oral glucocorticoids and proton pump inhibitors and risk of osteoporotic fractures among patients with rheumatoid arthritis: a population-based cohort study. Annals of the Rheumatic Diseases, 80(4), 423–431. [DOI] [Repository]
2020
Wetenschappelijke publicaties
Abtahi, S., Burden, A. M., Geusens, P., van den Bergh, J. P., van Staa, T., & de Vries, F. (2020). The Association of Oral Bisphosphonate Use With Mortality Risk Following a Major Osteoporotic Fracture in the United Kingdom: Population-Based Cohort Study. Journal of the American Medical Directors Association, 21(6), 811-816. [DOI] [Repository]
2019
Wetenschappelijke publicaties
Nasimi, M., Abedini, R., Daneshpazjooh, M., Esmaeilpour, A., Ghaedi, F., Teimourpour, A., & Abtahi, S. (2019). Illness perception of patients with pemphigus vulgaris. International Journal of Women's Dermatology, 5(2), 96-99. [DOI]
Abtahi, S., Driessen, JHM., Vestergaard, P., van, D. B. J., Boonen, A., de Vries, F., & Burden, AM. (2019). Secular trends in major osteoporotic fractures among 50+ adults in Denmark between 1995 and 2010. Osteoporosis International, 30(11), 2217-2223. [DOI] [Repository]
2018
Wetenschappelijke publicaties
Kamyab, K., Rezvani, M., Seirafi, H., Mortazavi, S., Teymourpour, A., Abtahi, S., & Nasimi, M. (2018). Distinguishing immunohistochemical features of alopecia areata from androgenic alopecia. Journal of Cosmetic Dermatology. [DOI]
Amiche, M. A., Abtahi, S., Driessen, J. H. M., Vestergaard, P., de Vries, F., Cadarette, S. M., & Burden, A. M. (2018). Impact of cumulative exposure to high-dose oral glucocorticoids on fracture risk in Denmark: a population-based case-control study. Archives of Osteoporosis, 13(1), 1-10. Article 30. [DOI] [Repository]
2017
Wetenschappelijke publicaties
Abtahi, S., Seirafi, H., Balighi, K., Ehsani, A. H., Farnaghi, F., & Mobasher, P. (2017). Psoralen and UltraViolet A in Atopic Dermatitis. Journal of Skin and Stem Cell, 4(2).
2014
Wetenschappelijke publicaties
Ebrahimifard, F., Shirvani, A., Abtahi, S., & Setayesh, A. (2014). Internal jugular catheter malposition in a patient with end stage renal disease: a case report. Acta Medica Iranica, 52(9), 721-724.
2004
Vakpublicaties
Abtahi, S., Rafiei, M., Fallahi, M., & Bastin, H. (2004). زیست شناسی سلولی و ملکولی (Cellular & Molecular Biology). Mir Publication, Tehran.